Showing results (171-180 of 184) with videos related to
Sort By:
Pageof 19
International Journal of Radiation Oncology, Biology, Physics|March 11, 2014
Phase 2 trial of induction gemcitabine, oxaliplatin, and cetuximab followed by selective capecitabine-based chemoradiation in patients with borderline resectable or unresectable locally advanced pancreatic cancerNestor F Esnaola, Uzair B Chaudhary, Paul O'Brien, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 25, 2005
Accurate discrimination of Barrett's esophagus and esophageal adenocarcinoma using a quantitative three-tiered algorithm and multimarker real-time reverse transcription-PCRMichael Mitas, Jonas S Almeida, Kaidi Mikhitarian, et al.Journal of Hepatology|August 14, 2016
Successful chemoimmunotherapy against hepatocellular cancer in a novel murine modelGuangfu Li, Dai Liu, Timothy K Cooper, et al.Iscience|May 10, 2021
Comparative analysis of antibodies to SARS-CoV-2 between asymptomatic and convalescent patientsConnor J Dwyer, Colleen A Cloud, Cindy Wang, et al.Nature Immunology|March 28, 2026
ZFP148 is a transcriptional repressor of cytolytic effector CD8<sup>+</sup> T cell differentiationTong Xiao, Xingyu Chen, No-Joon Song, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 17, 2012
A coreceptor-independent transgenic human TCR mediates anti-tumor and anti-self immunity in miceShikhar Mehrotra, Amir A Al-Khami, Jared Klarquist, et al.Annals of Surgery|May 10, 2013
A randomized phase II study of immunization with dendritic cells modified with poxvectors encoding CEA and MUC1 compared with the same poxvectors plus GM-CSF for resected metastatic colorectal cancerMichael A Morse, Donna Niedzwiecki, John L Marshall, et al.Cell Reports. Medicine|November 10, 2021
Neoadjuvant presurgical PD-1 inhibition in oral cavity squamous cell carcinomaHannah M Knochelmann, Joshua D Horton, Sixue Liu, et al.The Lancet. Oncology|April 10, 2018
ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trialJohn M Wrangle, Vamsidhar Velcheti, Manish R Patel, et al.JCI Insight|February 7, 2023
Selective suppression of de novo SARS-CoV-2 vaccine antibody responses in patients with cancer on B cell-targeted therapyJoseph H Azar, John P Evans, Madison H Sikorski, et al.Pageof 19